EPISODE · Jun 18, 2026 · 11 MIN
角色转变：肥胖治疗正在改变消化科的未来
from 消化肝病前沿资讯
本期播客深入探讨肥胖作为慢性代谢性疾病的现状，解析消化科医生角色的根本转变。内容涵盖MASLD等肝病风险、GLP-1类药物（如司美格鲁肽、替尔泊肽）的惊人疗效与心血管获益，以及内镜减重技术ESG的微创优势。同时讨论治疗中的不良反应管理、长期依从性挑战，并展望“代谢型胃肠照护”这一整合药物、内镜与营养管理的全新模式。00:06肥胖成慢性代谢疾病00:29消化科角色根本转变01:13MASLD进展与危害01:50肥胖伤胃肠机制02:32肠菌群与肥胖关联03:11GLP-1药物减重效果03:41替尔泊肽疗效对比04:26心血管获益与不良反应05:15用药胃肠反应管理05:56脂肪肝减重目标06:28肝病药物新进展07:09内镜减重技术介绍07:40ESG与药物效果对比08:10个体化方案与挑战08:53长期疗效与依从性09:25消化科医生独特角色10:12代谢型胃肠照护模式10:51肥胖治疗深刻变革11:34总结与听众寄语
Embed this episode
Ready to play
角色转变：肥胖治疗正在改变消化科的未来
0:00
11:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 消化肝病前沿资讯?
This episode is 11 minutes long.
When was this 消化肝病前沿资讯 episode published?
This episode was published on June 18, 2026.
Can I download this 消化肝病前沿资讯 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!